Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
No holdings reported for quarter Q2 2023 |
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
MYLAN N V | 7 | Q2 2019 | 4.6% |
ORMAT TECHNOLOGIES INC | 7 | Q2 2019 | 3.1% |
TOWER SEMICONDUCTOR LTD | 7 | Q2 2019 | 2.6% |
TEVA PHARMACEUTICAL INDS LTD | 7 | Q2 2019 | 3.3% |
ISHARES TR | 7 | Q2 2019 | 3.7% |
MELLANOX TECHNOLOGIES LTD | 7 | Q2 2019 | 2.4% |
SOLAREDGE TECHNOLOGIES INC | 7 | Q2 2019 | 2.0% |
SPDR S&P 500 ETF TR | 7 | Q2 2019 | 3.0% |
MOSAIC CO NEW | 7 | Q2 2019 | 2.3% |
ALPHABET INC | 7 | Q2 2019 | 1.7% |
View Delek Group, Ltd.'s complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
GULFSLOPE ENERGY, INC. | October 05, 2020 | 294,018,459 | 23.2% |
ELBIT SYSTEMS LTD | April 07, 2016 | 142,557,920 | 3.3% |
Evogene Ltd. | April 07, 2016 | 113,983,700 | 4.5% |
GILAT SATELLITE NETWORKS LTD | April 07, 2016 | 522,221,800 | 11.8% |
KAMADA LTD | April 07, 2016 | 284,982,644 | 7.9% |
NOVA MEASURING INSTRUMENTS LTD | April 07, 2016 | 352,797,400 | 12.9% |
ORMAT TECHNOLOGIES, INC. | April 07, 2016 | 261,068,716 | 5.3% |
PARTNER COMMUNICATIONS CO LTD | April 07, 2016 | 1,404,100,823 | 9.0% |
Protalix BioTherapeutics, Inc. | April 07, 2016 | 236,654,924 | 2.4% |
RETALIX LTD | April 16, 2012 | 649,501 | 2.7% |
View Delek Group, Ltd.'s complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
424B3 | 2021-01-08 |
F-6EF | 2021-01-07 |
4 | 2020-10-05 |
SC 13D/A | 2020-10-05 |
SC 13D/A | 2019-10-25 |
4 | 2019-10-24 |
13F-HR | 2019-08-08 |
13F-HR | 2019-05-13 |
SC 13D/A | 2019-03-27 |
3 | 2019-03-07 |
View Delek Group, Ltd.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.